Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with unresected stage I or II non–small cell lung cancer (NSCLC)…

Overview of attention for article published in Journal of Clinical Oncology, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 1 X user

Readers on

mendeley: 12 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,027 followers.

@teamoncology These were inoperable early nsclc. it will be good to see the details but presumably this is most relevant to lung radiation and the issues that made them inoperable. The QA on the SBRT will matter too. https://t.co/IXMZp3ILoT

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.